Section Arrow
Quote
REVB.NASDAQ
- Revelation Biosciences Inc.
Quotes are at least 15-min delayed:2026/04/01 17:30 EDT
After Hours
Last
 1.18
-0.05 (-4.07%)
Bid
1.18
Ask
1.23
High 1.23 
Low 1.17 
Volume 451 
Regular Hours (Closed)
Last
 1.23
+0.03 (+2.50%)
Day High 
1.23 
Prev. Close
1.2 
1-M High
1.4276 
Volume 
42.88K 
Bid
1.18
Ask
1.23
Day Low
1.18 
Open
1.23 
1-M Low
1.06 
Market Cap 
3.15M 
Currency 美元 
P/E 0 
%Yield -- 
10-SMA 1.18 
20-SMA 1.22 
50-SMA 1.57 
52-W High 44.76996 
52-W Low 1.06 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-23.95/-3.30
Enterprise Value
3.87M
Balance Sheet
Book Value Per Share
2.38
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
CYCNCyclerion Therapeutics6.38+4.83+311.61%-- 
After Hours 5.95 -0.43 -6.74%
ELABPmgc Holdings Inc14+8.01+133.72%0PE
After Hours 8.69 -5.31 -37.93%
IOBTIO Biotech0.0437-0.015-25.55%-- 
After Hours 0.0422 -0.0015 -3.43%
APLSApellis Pharmaceuticals40.39+0.16+0.40%224.11PE
After Hours 40.36 -0.03 -0.07%
GERNGeron Corp1.66+0.17+11.41%-- 
After Hours 1.66 0 0.00%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Revelation Biosciences Inc is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini. The company is developing a pipeline of potential products based on Gemini, which is its proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA). PHAD is a small fragment of lipopolysaccharide (LPS) that stimulates TLR4 and leads to controlled production of multiple cytokines and chemokines that modulate the innate and adaptive immune response. The company operates through one reportable segment focused on the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.